During the past decade, Tauranga Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 16 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tauranga Hospital" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "BeiGene" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tauranga Hospital" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Berry Consultants" with 2 trials as a collaborator, "Intensive Care National Audit & Research Centre" with 2 trials as a collaborator and "Medical Research Institute of New Zealand" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Tauranga Hospital" are "Chronic Lymphocytic Leukemia" (3 trials), "Idiopathic Pulmonary Fibrosis" (3 trials), "Small Lymphocytic Lymphoma" (3 trials), "Crohn Disease" (2 trials) and "Influenza" (2 trials). Many other conditions were trialed in "Tauranga Hospital" in a lesser frequency.

Most popular intervention types in "Tauranga Hospital" are "Drug" (39 trials), "Other" (6 trials), "Biological" (2 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Etrolizumab" (4 trials), "Bendamustine" (2 trials), "MHAA4549A" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tauranga Hospital" are 42 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tauranga Hospital". undefined are not yet recruiting, 7 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Tauranga Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Tauranga Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".